翻訳と辞書 Words near each other ・ Paramycetophylax ・ Paramyiolia ・ Paramylodon ・ Paramylon ・ Paramylostoma ・ Paramyopsyche ・ Paramyotonia congenita ・ Paramyromeus loriai ・ Paramys ・ Paramysis ・ Paramysis baeri ・ Paramysis bakuensis ・ Paramount Animation ・ Paramount Arts Center ・ Paramount Bay at Edgewater Square ・ Paramount BioCapital ・ Paramount Cabinaire ・ Paramount Canadians Party ・ Paramount Capital ・ Paramount Cars ・ Paramount Channel (international) ・ Paramount chief ・ Paramount Chief Mpezeni ・ Paramount Chief Tuli Le’iato ・ Paramount chieftain ・ Paramount College of Natural Medicine ・ Paramount Comedy ・ Paramount Comedy Spain ・ Paramount Comics ・ Paramount Communications, Inc. v. QVC Network, Inc. Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Paramount BioCapital ： ウィキペディア英語版 Paramount BioCapital Paramount BioCapital, Inc., an affiliate of Paramount Capital group of companies, is a broker-dealer registered by the Financial Industry Regulatory Authority (FINRA)〔(【引用サイトリンク】title=NILE THERAPEUTICS INC Officers & Directors )〕 and investment firm in the United States that specializes in conducting private financings for public and private development stage biotechnology companies and promising in-licensed drug candidates. ==Background/history== In 1991 Lindsay A. Rosenwald, M.D., established Paramount BioCapital that, among other activities, has since been raising capital for the Paramount Capital Portfolio Companies. More than 40 starts up companies, including Cougar Biotechnology, Bionovo Inc., Ziopharm Oncology, Innovive Pharmaceuticals,''Novadel Pharma'', Tikvah Therapeutics, Inc.,〔 〕 VioQuest Pharmaceuticals, and many others have been created over the past 19 years. Since its inception, Paramount BioCapital and its affiliate companies have been involved in the clinical development of more than 50 drug candidates, some of which have reached the market (including leukemia drug, Arsenic Trioxide, which progressed from Investigational New Drug to New Drug Application in about 30 months — the fastest regulatory approval in U.S. Food and Drug Administration (FDA) history; Sulodexide (KRX-101) for diabetic nephropathy licensed into Keryx Biopharmaceuticals, Inc.; milnacipran for fibromyalgia syndrome licensed from Pierre Fabre Medicament; CH-1504 (MobileTrex) for rheumatoid arthritis licensed from University of South Alabama College of Medicine by Chelsea Therapeutics. Over 30 compounds still undergo clinical development today. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Paramount BioCapital」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.